Full text is available at the source.
Abstract
Transplantation of AQP4-modified mesenchymal stem cells significantly reduced cerebral edema and blood-brain barrier disruption in a mouse model of intracerebral hemorrhage.
- AQP4-modified mesenchymal stem cells improved neurological function and stabilized astrocyte morphology.
- These cells enhanced glymphatic transport and waste clearance after intracerebral hemorrhage.
- AQP4-modified mesenchymal stem cells decreased inflammatory cytokine secretion.
- The therapy increased the release of glial cell line-derived neurotrophic factor.
- AQP4 was found to bind directly to TLR4 on glial cells, which may block inflammatory stimulation and inhibit neuronal injury.
Simplified